StockClub

VRAX

VRAXVirax Biolabs Group Limited$ --
Virax Biolabs Group Limited

Virax Biolabs Group Limited

VRAX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q4
Revenue
0M USD
YoY +684.8%
Operating Income
-4M USD
YoY -16.1%
Net Income
-3M USD
YoY +18.8%
EPS
-4.44$
YoY +76.6%

Revenue

$12,423
FY2023 Q2$5,760
$5,760
Q2
FY2023 Q4$8,561
$8,561
Q4
FY2024 Q2$76,500
$76,500
Q2
FY2024 Q4$156,419
$156,419
Q4
FY2025 Q2$4,953
$4,953
Q2
FY2025 Q4$6,331
$6,331
Q4
FY2026 Q2$1,608
$1,608
Q2
FY2026 Q4$12,423
$12,423
Q4
Actual
+$6,092 (+96.2%)

Net Income

$-5M
FY2023 Q2$-1.4M
$-1.4M
Q2
FY2023 Q4$-5.5M
$-5.5M
Q4
FY2024 Q2$-2.9M
$-2.9M
Q2
FY2024 Q4$-6.7M
$-6.7M
Q4
FY2025 Q2$-2.8M
$-2.8M
Q2
FY2025 Q4$-6.1M
$-6.1M
Q4
FY2026 Q2$-2.3M
$-2.3M
Q2
FY2026 Q4$-5M
$-5M
Q4
Actual
+$1M (+17.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2021
Actual:$123,820
FY2021
$123,820
FY2022
Actual:$0
FY2022
$0
FY2023MISS
Actual:$8,561
Est:$200,000
FY2023MISS
$8,561
FY2024MISS
Actual:$156,419
Est:$1.4M
FY2024MISS
$156,419
FY2025MISS
Actual:$6,331
Est:$25,000
FY2025MISS
$6,331
FY2026MISS
Actual:$12,423
Est:$40,000
FY2026MISS
$12,423

Analyst Estimates